2021 has been a challenging year worldwide. Unfortunately, the COVID-19 pandemic is not over yet, and it continues to impact public health, society, and the economy. Our project has also suffered due to pandemics, with having a low recruitment rate for SMA-TB Clinical Trial. And yet, we feel content with the results and achievements we have this year.
I am happy to share our 2nd SMA-TB newsletter. The communication dimension is vital for us; with various tools and approaches, we share the project’s achievements with the world, but we also intend to be helpful for patients and the team members. On this note, I hope you will find our newsletter beneficial for you to learn more about SMA-TB and collaborate with us in case of interest.
Dr. Cris Vilaplana, SMA-TB Project Coordinator
